title: Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Schamun
authors.forename: Eduardo
authors.initials: E
authors.lastname: Bullorsky
authors.forename: German
authors.initials: G
authors.lastname: Stemmelin
authors.forename: Ricardo
authors.initials: R
authors.lastname: Saxton
authors.forename: Daniel
authors.initials: D
authors.lastname: Ricchione
mesh_terms: D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D016572:Cyclosporine / Q000008:administration & dosage*; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D007166:Immunosuppressive Agents; D010879:Piperazines; D011743:Pyrimidines; D016572:Cyclosporine; D000068877:Imatinib Mesylate